IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells
Masahiro Kondo(Nihon University), Yoshiya Tanaka(University of Occupational and Environmental Health Japan)
Cited by 51
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|413